Elias Sayour, MD, PhD is a board-certified pediatric oncologist and Associate Professor of Neurosurgery and Pediatrics. He serves as Assistant Dean of Clinical Research in the UF College of Medicine, Vice Chair of the UF Health Cancer Center (UFHCC) Scientific Review Monitoring Committee (SRMC), and Co-leader of Cancer Therapy and Host Response (CTHR) Program. Dr. Sayour has extensive translational experience having served as sponsor of multiple FDA-IND submissions and as PI/Study Chair on first-in-human clinical trials (NCT03334305, NCT04573140).
He serves as institutional PI for the Pediatric Brain Tumor Consortium (PBTC) and Pacific Pediatric Neuro-Oncology Consortium (PNOC) and has spearheaded creation of the UF Pediatric Cancer Immunotherapy Initiative (PCI2) and Large Animal Comparative Oncology Initiative. He serves as principal investigator of the RNA Engineering Laboratory where he has been the primary inventor on a number of pending patent applications concerning the immunologic treatment of cancer. He received UF’s 2021 Innovation of the Year Award, and recognition as a University of Florida Term Professor.